Concepedia

Ronald J. Doll

RJ

43

Publications

3.6K

Citations

30

H-Index

1957

Active since

Affiliations

AIL Research (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

AGCO (United Kingdom)

Ronald J. Doll is an author at AIL Research (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

MedicinePharmacologyDrug DiscoveryBiochemistryNatural SciencesMedicinal ChemistryChemical BiologyDrug DevelopmentTumor BiologyPharmacotherapy

Publications per year

1957–2018

43

Publications

43

A Two-stage Theory of Carcinogenesis in Relation to the Age Distribution of Human Cancer

P. Armitage, Ronald J. Doll · British Journal of Cancer · 1957 · 559 citations · Full text

Two-stage Theory, Malignant Disease, Medicine +11

Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor

David Parry, Timothy J. Guzi, Nicole R. Davis et al. · Molecular Cancer Therapeutics · 2010 · 553 citations · Full text

Pharmacotherapy, Cancer Biology, Tumor Biology +16

Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.

Ming Liu, Matthew Bryant, Jianping Chen et al. · PubMed · 1998 · 309 citations

Sch 66336, Chemoprevention Strategy, Farnesyl Protein Transferase +15

Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases

Kamil Paruch, Michael P. Dwyer, Carmen Álvarez et al. · ACS Medicinal Chemistry Letters · 2010 · 174 citations · Full text

Drug Target, Pathology, Chemical Biology +21

Novel Tricyclic Inhibitors of Farnesyl Protein Transferase

W. Robert Bishop, Richard Bond, Joanne Petrin et al. · Journal of Biological Chemistry · 1995 · 155 citations · Full text

Rows per page

1–5 of 43